 | • レポートコード：MRC2-11QY02220 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はアルコール性肝炎薬のグローバル市場について調査・分析したレポートです。種類別（F-652、GRI-0621、HepaStem、IMM-124E、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別アルコール性肝炎薬の競争状況、市場シェア ・世界のアルコール性肝炎薬市場：種類別市場規模 2015年-2020年（F-652、GRI-0621、HepaStem、IMM-124E、その他） ・世界のアルコール性肝炎薬市場：種類別市場規模予測 2021年-2026年（F-652、GRI-0621、HepaStem、IMM-124E、その他） ・世界のアルコール性肝炎薬市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界のアルコール性肝炎薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米のアルコール性肝炎薬市場分析：米国、カナダ ・ヨーロッパのアルコール性肝炎薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのアルコール性肝炎薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のアルコール性肝炎薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのアルコール性肝炎薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Alfact Innovation、Generon (Shanghai) Corp Ltd、Gilead Sciences Inc、GRI Bio Inc、Immuron Ltd、Intercept Pharmaceuticals Inc、Promethera Biosciences SA、Verlyx Pharma Inc、Vital Therapies Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Alcoholic Hepatiti Drug Market
The global Alcoholic Hepatiti Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Alcoholic Hepatiti Drug Scope and Market Size
Alcoholic Hepatiti Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Alcoholic Hepatiti Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Alcoholic Hepatiti Drug market is segmented into
F-652
GRI-0621
HepaStem
IMM-124E
Others
Segment by Application, the Alcoholic Hepatiti Drug market is segmented into
Hospital
Clinic
Others
Regional and Country-level Analysis
The Alcoholic Hepatiti Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Alcoholic Hepatiti Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Alcoholic Hepatiti Drug Market Share Analysis
Alcoholic Hepatiti Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Alcoholic Hepatiti Drug business, the date to enter into the Alcoholic Hepatiti Drug market, Alcoholic Hepatiti Drug product introduction, recent developments, etc.
The major vendors covered:
Alfact Innovation
Generon (Shanghai) Corp Ltd
Gilead Sciences Inc
GRI Bio Inc
Immuron Ltd
Intercept Pharmaceuticals Inc
Promethera Biosciences SA
Verlyx Pharma Inc
Vital Therapies Inc
1 Study Coverage
1.1 Alcoholic Hepatiti Drug Product Introduction
1.2 Market Segments
1.3 Key Alcoholic Hepatiti Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Alcoholic Hepatiti Drug Market Size Growth Rate by Type
1.4.2 F-652
1.4.3 GRI-0621
1.4.4 HepaStem
1.4.5 IMM-124E
1.4.6 Others
1.5 Market by Application
1.5.1 Global Alcoholic Hepatiti Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Alcoholic Hepatiti Drug Market Size, Estimates and Forecasts
2.1.1 Global Alcoholic Hepatiti Drug Revenue 2015-2026
2.1.2 Global Alcoholic Hepatiti Drug Sales 2015-2026
2.2 Global Alcoholic Hepatiti Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Alcoholic Hepatiti Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Alcoholic Hepatiti Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Alcoholic Hepatiti Drug Competitor Landscape by Players
3.1 Alcoholic Hepatiti Drug Sales by Manufacturers
3.1.1 Alcoholic Hepatiti Drug Sales by Manufacturers (2015-2020)
3.1.2 Alcoholic Hepatiti Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Alcoholic Hepatiti Drug Revenue by Manufacturers
3.2.1 Alcoholic Hepatiti Drug Revenue by Manufacturers (2015-2020)
3.2.2 Alcoholic Hepatiti Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Alcoholic Hepatiti Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Alcoholic Hepatiti Drug Revenue in 2019
3.2.5 Global Alcoholic Hepatiti Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Alcoholic Hepatiti Drug Price by Manufacturers
3.4 Alcoholic Hepatiti Drug Manufacturing Base Distribution, Product Types
3.4.1 Alcoholic Hepatiti Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Alcoholic Hepatiti Drug Product Type
3.4.3 Date of International Manufacturers Enter into Alcoholic Hepatiti Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Alcoholic Hepatiti Drug Market Size by Type (2015-2020)
4.1.1 Global Alcoholic Hepatiti Drug Sales by Type (2015-2020)
4.1.2 Global Alcoholic Hepatiti Drug Revenue by Type (2015-2020)
4.1.3 Alcoholic Hepatiti Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Alcoholic Hepatiti Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Alcoholic Hepatiti Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Alcoholic Hepatiti Drug Revenue Forecast by Type (2021-2026)
4.2.3 Alcoholic Hepatiti Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Alcoholic Hepatiti Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Alcoholic Hepatiti Drug Market Size by Application (2015-2020)
5.1.1 Global Alcoholic Hepatiti Drug Sales by Application (2015-2020)
5.1.2 Global Alcoholic Hepatiti Drug Revenue by Application (2015-2020)
5.1.3 Alcoholic Hepatiti Drug Price by Application (2015-2020)
5.2 Alcoholic Hepatiti Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Alcoholic Hepatiti Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Alcoholic Hepatiti Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Alcoholic Hepatiti Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Alcoholic Hepatiti Drug by Country
6.1.1 North America Alcoholic Hepatiti Drug Sales by Country
6.1.2 North America Alcoholic Hepatiti Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Alcoholic Hepatiti Drug Market Facts & Figures by Type
6.3 North America Alcoholic Hepatiti Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Alcoholic Hepatiti Drug by Country
7.1.1 Europe Alcoholic Hepatiti Drug Sales by Country
7.1.2 Europe Alcoholic Hepatiti Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Alcoholic Hepatiti Drug Market Facts & Figures by Type
7.3 Europe Alcoholic Hepatiti Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Alcoholic Hepatiti Drug by Region
8.1.1 Asia Pacific Alcoholic Hepatiti Drug Sales by Region
8.1.2 Asia Pacific Alcoholic Hepatiti Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Alcoholic Hepatiti Drug Market Facts & Figures by Type
8.3 Asia Pacific Alcoholic Hepatiti Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Alcoholic Hepatiti Drug by Country
9.1.1 Latin America Alcoholic Hepatiti Drug Sales by Country
9.1.2 Latin America Alcoholic Hepatiti Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Alcoholic Hepatiti Drug Market Facts & Figures by Type
9.3 Central & South America Alcoholic Hepatiti Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Alcoholic Hepatiti Drug by Country
10.1.1 Middle East and Africa Alcoholic Hepatiti Drug Sales by Country
10.1.2 Middle East and Africa Alcoholic Hepatiti Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Alcoholic Hepatiti Drug Market Facts & Figures by Type
10.3 Middle East and Africa Alcoholic Hepatiti Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Alfact Innovation
11.1.1 Alfact Innovation Corporation Information
11.1.2 Alfact Innovation Description and Business Overview
11.1.3 Alfact Innovation Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Alfact Innovation Alcoholic Hepatiti Drug Products Offered
11.1.5 Alfact Innovation Related Developments
11.2 Generon (Shanghai) Corp Ltd
11.2.1 Generon (Shanghai) Corp Ltd Corporation Information
11.2.2 Generon (Shanghai) Corp Ltd Description and Business Overview
11.2.3 Generon (Shanghai) Corp Ltd Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Generon (Shanghai) Corp Ltd Alcoholic Hepatiti Drug Products Offered
11.2.5 Generon (Shanghai) Corp Ltd Related Developments
11.3 Gilead Sciences Inc
11.3.1 Gilead Sciences Inc Corporation Information
11.3.2 Gilead Sciences Inc Description and Business Overview
11.3.3 Gilead Sciences Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Gilead Sciences Inc Alcoholic Hepatiti Drug Products Offered
11.3.5 Gilead Sciences Inc Related Developments
11.4 GRI Bio Inc
11.4.1 GRI Bio Inc Corporation Information
11.4.2 GRI Bio Inc Description and Business Overview
11.4.3 GRI Bio Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 GRI Bio Inc Alcoholic Hepatiti Drug Products Offered
11.4.5 GRI Bio Inc Related Developments
11.5 Immuron Ltd
11.5.1 Immuron Ltd Corporation Information
11.5.2 Immuron Ltd Description and Business Overview
11.5.3 Immuron Ltd Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Immuron Ltd Alcoholic Hepatiti Drug Products Offered
11.5.5 Immuron Ltd Related Developments
11.6 Intercept Pharmaceuticals Inc
11.6.1 Intercept Pharmaceuticals Inc Corporation Information
11.6.2 Intercept Pharmaceuticals Inc Description and Business Overview
11.6.3 Intercept Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Intercept Pharmaceuticals Inc Alcoholic Hepatiti Drug Products Offered
11.6.5 Intercept Pharmaceuticals Inc Related Developments
11.7 Promethera Biosciences SA
11.7.1 Promethera Biosciences SA Corporation Information
11.7.2 Promethera Biosciences SA Description and Business Overview
11.7.3 Promethera Biosciences SA Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Promethera Biosciences SA Alcoholic Hepatiti Drug Products Offered
11.7.5 Promethera Biosciences SA Related Developments
11.8 Verlyx Pharma Inc
11.8.1 Verlyx Pharma Inc Corporation Information
11.8.2 Verlyx Pharma Inc Description and Business Overview
11.8.3 Verlyx Pharma Inc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Verlyx Pharma Inc Alcoholic Hepatiti Drug Products Offered
11.8.5 Verlyx Pharma Inc Related Developments
11.9 Vital Therapies Inc
11.9.1 Vital Therapies Inc Corporation Information
11.9.2 Vital Therapies Inc Description and Business Overview
11.9.3 Vital Therapies Inc Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Vital Therapies Inc Alcoholic Hepatiti Drug Products Offered
11.9.5 Vital Therapies Inc Related Developments
11.1 Alfact Innovation
11.1.1 Alfact Innovation Corporation Information
11.1.2 Alfact Innovation Description and Business Overview
11.1.3 Alfact Innovation Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Alfact Innovation Alcoholic Hepatiti Drug Products Offered
11.1.5 Alfact Innovation Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Alcoholic Hepatiti Drug Market Estimates and Projections by Region
12.1.1 Global Alcoholic Hepatiti Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Alcoholic Hepatiti Drug Revenue Forecast by Regions 2021-2026
12.2 North America Alcoholic Hepatiti Drug Market Size Forecast (2021-2026)
12.2.1 North America: Alcoholic Hepatiti Drug Sales Forecast (2021-2026)
12.2.2 North America: Alcoholic Hepatiti Drug Revenue Forecast (2021-2026)
12.2.3 North America: Alcoholic Hepatiti Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Alcoholic Hepatiti Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Alcoholic Hepatiti Drug Sales Forecast (2021-2026)
12.3.2 Europe: Alcoholic Hepatiti Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Alcoholic Hepatiti Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Alcoholic Hepatiti Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Alcoholic Hepatiti Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Alcoholic Hepatiti Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Alcoholic Hepatiti Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Alcoholic Hepatiti Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Alcoholic Hepatiti Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Alcoholic Hepatiti Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Alcoholic Hepatiti Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Alcoholic Hepatiti Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Alcoholic Hepatiti Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Alcoholic Hepatiti Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Alcoholic Hepatiti Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Alcoholic Hepatiti Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Alcoholic Hepatiti Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Alcoholic Hepatiti Drug Market Segments
Table 2. Ranking of Global Top Alcoholic Hepatiti Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Alcoholic Hepatiti Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of F-652
Table 5. Major Manufacturers of GRI-0621
Table 6. Major Manufacturers of HepaStem
Table 7. Major Manufacturers of IMM-124E
Table 8. Major Manufacturers of Others
Table 9. Global Alcoholic Hepatiti Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Alcoholic Hepatiti Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Alcoholic Hepatiti Drug Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Alcoholic Hepatiti Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Alcoholic Hepatiti Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Alcoholic Hepatiti Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Alcoholic Hepatiti Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Alcoholic Hepatiti Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Alcoholic Hepatiti Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alcoholic Hepatiti Drug as of 2019)
Table 18. Alcoholic Hepatiti Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Alcoholic Hepatiti Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Alcoholic Hepatiti Drug Price (2015-2020) (USD/Pcs)
Table 21. Alcoholic Hepatiti Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Alcoholic Hepatiti Drug Product Type
Table 23. Date of International Manufacturers Enter into Alcoholic Hepatiti Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Alcoholic Hepatiti Drug Sales by Type (2015-2020) (K Pcs)
Table 26. Global Alcoholic Hepatiti Drug Sales Share by Type (2015-2020)
Table 27. Global Alcoholic Hepatiti Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Alcoholic Hepatiti Drug Revenue Share by Type (2015-2020)
Table 29. Alcoholic Hepatiti Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Alcoholic Hepatiti Drug Sales by Application (2015-2020) (K Pcs)
Table 31. Global Alcoholic Hepatiti Drug Sales Share by Application (2015-2020)
Table 32. North America Alcoholic Hepatiti Drug Sales by Country (2015-2020) (K Pcs)
Table 33. North America Alcoholic Hepatiti Drug Sales Market Share by Country (2015-2020)
Table 34. North America Alcoholic Hepatiti Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Alcoholic Hepatiti Drug Revenue Market Share by Country (2015-2020)
Table 36. North America Alcoholic Hepatiti Drug Sales by Type (2015-2020) (K Pcs)
Table 37. North America Alcoholic Hepatiti Drug Sales Market Share by Type (2015-2020)
Table 38. North America Alcoholic Hepatiti Drug Sales by Application (2015-2020) (K Pcs)
Table 39. North America Alcoholic Hepatiti Drug Sales Market Share by Application (2015-2020)
Table 40. Europe Alcoholic Hepatiti Drug Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Alcoholic Hepatiti Drug Sales Market Share by Country (2015-2020)
Table 42. Europe Alcoholic Hepatiti Drug Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Alcoholic Hepatiti Drug Revenue Market Share by Country (2015-2020)
Table 44. Europe Alcoholic Hepatiti Drug Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Alcoholic Hepatiti Drug Sales Market Share by Type (2015-2020)
Table 46. Europe Alcoholic Hepatiti Drug Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Alcoholic Hepatiti Drug Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Alcoholic Hepatiti Drug Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Alcoholic Hepatiti Drug Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Alcoholic Hepatiti Drug Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Alcoholic Hepatiti Drug Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Alcoholic Hepatiti Drug Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Alcoholic Hepatiti Drug Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Alcoholic Hepatiti Drug Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Alcoholic Hepatiti Drug Sales Market Share by Application (2015-2020)
Table 56. Latin America Alcoholic Hepatiti Drug Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Alcoholic Hepatiti Drug Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Alcoholic Hepatiti Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Alcoholic Hepatiti Drug Revenue Market Share by Country (2015-2020)
Table 60. Latin America Alcoholic Hepatiti Drug Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Alcoholic Hepatiti Drug Sales Market Share by Type (2015-2020)
Table 62. Latin America Alcoholic Hepatiti Drug Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Alcoholic Hepatiti Drug Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Alcoholic Hepatiti Drug Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Alcoholic Hepatiti Drug Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Alcoholic Hepatiti Drug Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Alcoholic Hepatiti Drug Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Alcoholic Hepatiti Drug Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Alcoholic Hepatiti Drug Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Alcoholic Hepatiti Drug Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Alcoholic Hepatiti Drug Sales Market Share by Application (2015-2020)
Table 72. Alfact Innovation Corporation Information
Table 73. Alfact Innovation Description and Major Businesses
Table 74. Alfact Innovation Alcoholic Hepatiti Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Alfact Innovation Product
Table 76. Alfact Innovation Recent Development
Table 77. Generon (Shanghai) Corp Ltd Corporation Information
Table 78. Generon (Shanghai) Corp Ltd Description and Major Businesses
Table 79. Generon (Shanghai) Corp Ltd Alcoholic Hepatiti Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Generon (Shanghai) Corp Ltd Product
Table 81. Generon (Shanghai) Corp Ltd Recent Development
Table 82. Gilead Sciences Inc Corporation Information
Table 83. Gilead Sciences Inc Description and Major Businesses
Table 84. Gilead Sciences Inc Alcoholic Hepatiti Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Gilead Sciences Inc Product
Table 86. Gilead Sciences Inc Recent Development
Table 87. GRI Bio Inc Corporation Information
Table 88. GRI Bio Inc Description and Major Businesses
Table 89. GRI Bio Inc Alcoholic Hepatiti Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. GRI Bio Inc Product
Table 91. GRI Bio Inc Recent Development
Table 92. Immuron Ltd Corporation Information
Table 93. Immuron Ltd Description and Major Businesses
Table 94. Immuron Ltd Alcoholic Hepatiti Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Immuron Ltd Product
Table 96. Immuron Ltd Recent Development
Table 97. Intercept Pharmaceuticals Inc Corporation Information
Table 98. Intercept Pharmaceuticals Inc Description and Major Businesses
Table 99. Intercept Pharmaceuticals Inc Alcoholic Hepatiti Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Intercept Pharmaceuticals Inc Product
Table 101. Intercept Pharmaceuticals Inc Recent Development
Table 102. Promethera Biosciences SA Corporation Information
Table 103. Promethera Biosciences SA Description and Major Businesses
Table 104. Promethera Biosciences SA Alcoholic Hepatiti Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Promethera Biosciences SA Product
Table 106. Promethera Biosciences SA Recent Development
Table 107. Verlyx Pharma Inc Corporation Information
Table 108. Verlyx Pharma Inc Description and Major Businesses
Table 109. Verlyx Pharma Inc Alcoholic Hepatiti Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Verlyx Pharma Inc Product
Table 111. Verlyx Pharma Inc Recent Development
Table 112. Vital Therapies Inc Corporation Information
Table 113. Vital Therapies Inc Description and Major Businesses
Table 114. Vital Therapies Inc Alcoholic Hepatiti Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Vital Therapies Inc Product
Table 116. Vital Therapies Inc Recent Development
Table 117. Global Alcoholic Hepatiti Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 118. Global Alcoholic Hepatiti Drug Sales Market Share Forecast by Regions (2021-2026)
Table 119. Global Alcoholic Hepatiti Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 120. Global Alcoholic Hepatiti Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 121. North America: Alcoholic Hepatiti Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 122. North America: Alcoholic Hepatiti Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Europe: Alcoholic Hepatiti Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 124. Europe: Alcoholic Hepatiti Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Asia Pacific: Alcoholic Hepatiti Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 126. Asia Pacific: Alcoholic Hepatiti Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 127. Latin America: Alcoholic Hepatiti Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 128. Latin America: Alcoholic Hepatiti Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Middle East and Africa: Alcoholic Hepatiti Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 130. Middle East and Africa: Alcoholic Hepatiti Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 132. Key Challenges
Table 133. Market Risks
Table 134. Main Points Interviewed from Key Alcoholic Hepatiti Drug Players
Table 135. Alcoholic Hepatiti Drug Customers List
Table 136. Alcoholic Hepatiti Drug Distributors List
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Alcoholic Hepatiti Drug Product Picture
Figure 2. Global Alcoholic Hepatiti Drug Sales Market Share by Type in 2020 & 2026
Figure 3. F-652 Product Picture
Figure 4. GRI-0621 Product Picture
Figure 5. HepaStem Product Picture
Figure 6. IMM-124E Product Picture
Figure 7. Others Product Picture
Figure 8. Global Alcoholic Hepatiti Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Alcoholic Hepatiti Drug Report Years Considered
Figure 13. Global Alcoholic Hepatiti Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Alcoholic Hepatiti Drug Sales 2015-2026 (K Pcs)
Figure 15. Global Alcoholic Hepatiti Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Alcoholic Hepatiti Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Alcoholic Hepatiti Drug Sales Market Share by Region in 2019
Figure 18. Global Alcoholic Hepatiti Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Alcoholic Hepatiti Drug Revenue Market Share by Region in 2019
Figure 20. Global Alcoholic Hepatiti Drug Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Alcoholic Hepatiti Drug Revenue in 2019
Figure 22. Alcoholic Hepatiti Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Alcoholic Hepatiti Drug Sales Market Share by Type (2015-2020)
Figure 24. Global Alcoholic Hepatiti Drug Sales Market Share by Type in 2019
Figure 25. Global Alcoholic Hepatiti Drug Revenue Market Share by Type (2015-2020)
Figure 26. Global Alcoholic Hepatiti Drug Revenue Market Share by Type in 2019
Figure 27. Global Alcoholic Hepatiti Drug Market Share by Price Range (2015-2020)
Figure 28. Global Alcoholic Hepatiti Drug Sales Market Share by Application (2015-2020)
Figure 29. Global Alcoholic Hepatiti Drug Sales Market Share by Application in 2019
Figure 30. Global Alcoholic Hepatiti Drug Revenue Market Share by Application (2015-2020)
Figure 31. Global Alcoholic Hepatiti Drug Revenue Market Share by Application in 2019
Figure 32. North America Alcoholic Hepatiti Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Alcoholic Hepatiti Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Alcoholic Hepatiti Drug Sales Market Share by Country in 2019
Figure 35. North America Alcoholic Hepatiti Drug Revenue Market Share by Country in 2019
Figure 36. U.S. Alcoholic Hepatiti Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Alcoholic Hepatiti Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Alcoholic Hepatiti Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Alcoholic Hepatiti Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Alcoholic Hepatiti Drug Market Share by Type in 2019
Figure 41. North America Alcoholic Hepatiti Drug Market Share by Application in 2019
Figure 42. Europe Alcoholic Hepatiti Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Alcoholic Hepatiti Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Alcoholic Hepatiti Drug Sales Market Share by Country in 2019
Figure 45. Europe Alcoholic Hepatiti Drug Revenue Market Share by Country in 2019
Figure 46. Germany Alcoholic Hepatiti Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Alcoholic Hepatiti Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Alcoholic Hepatiti Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Alcoholic Hepatiti Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Alcoholic Hepatiti Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Alcoholic Hepatiti Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Alcoholic Hepatiti Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Alcoholic Hepatiti Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Alcoholic Hepatiti Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Alcoholic Hepatiti Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Alcoholic Hepatiti Drug Market Share by Type in 2019
Figure 57. Europe Alcoholic Hepatiti Drug Market Share by Application in 2019
Figure 58. Asia Pacific Alcoholic Hepatiti Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Alcoholic Hepatiti Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Alcoholic Hepatiti Drug Sales Market Share by Region in 2019
Figure 61. Asia Pacific Alcoholic Hepatiti Drug Revenue Market Share by Region in 2019
Figure 62. China Alcoholic Hepatiti Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Alcoholic Hepatiti Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Alcoholic Hepatiti Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Alcoholic Hepatiti Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Alcoholic Hepatiti Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Alcoholic Hepatiti Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Alcoholic Hepatiti Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Alcoholic Hepatiti Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Alcoholic Hepatiti Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Alcoholic Hepatiti Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Alcoholic Hepatiti Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Alcoholic Hepatiti Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Alcoholic Hepatiti Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Alcoholic Hepatiti Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Alcoholic Hepatiti Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Alcoholic Hepatiti Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Alcoholic Hepatiti Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Alcoholic Hepatiti Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Alcoholic Hepatiti Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Alcoholic Hepatiti Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Alcoholic Hepatiti Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Alcoholic Hepatiti Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Alcoholic Hepatiti Drug Market Share by Type in 2019
Figure 85. Asia Pacific Alcoholic Hepatiti Drug Market Share by Application in 2019
Figure 86. Latin America Alcoholic Hepatiti Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Alcoholic Hepatiti Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Alcoholic Hepatiti Drug Sales Market Share by Country in 2019
Figure 89. Latin America Alcoholic Hepatiti Drug Revenue Market Share by Country in 2019
Figure 90. Mexico Alcoholic Hepatiti Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Alcoholic Hepatiti Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Alcoholic Hepatiti Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Alcoholic Hepatiti Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Alcoholic Hepatiti Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Alcoholic Hepatiti Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Alcoholic Hepatiti Drug Market Share by Type in 2019
Figure 97. Latin America Alcoholic Hepatiti Drug Market Share by Application in 2019
Figure 98. Middle East and Africa Alcoholic Hepatiti Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Alcoholic Hepatiti Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Alcoholic Hepatiti Drug Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Alcoholic Hepatiti Drug Revenue Market Share by Country in 2019
Figure 102. Turkey Alcoholic Hepatiti Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Alcoholic Hepatiti Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Alcoholic Hepatiti Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Alcoholic Hepatiti Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Alcoholic Hepatiti Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Alcoholic Hepatiti Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Alcoholic Hepatiti Drug Market Share by Type in 2019
Figure 109. Middle East and Africa Alcoholic Hepatiti Drug Market Share by Application in 2019
Figure 110. North America Alcoholic Hepatiti Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Alcoholic Hepatiti Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Alcoholic Hepatiti Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Alcoholic Hepatiti Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Alcoholic Hepatiti Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Alcoholic Hepatiti Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Alcoholic Hepatiti Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Alcoholic Hepatiti Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Alcoholic Hepatiti Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Alcoholic Hepatiti Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
非アルコール性脂肪性肝疾患治療の世界市場（～2026年） Fatty liver disease refers to the accumulation of fat (triglycerides,) in the liver. The liver cell contains fats, but the accumulation of excess fat can be a cause of concern and can lead to liver inflammation known as steatohepatitis. The fatty liver can be caused by alcohol as well as can be non-…- 非アルコール性脂肪性肝炎（NASH）治療薬の世界市場（～2026年） Nonalcoholic steatohepatitis is a form of liver disease that develops in patients who are not alcoholic. The major feature in NASH is fat deposition in the liver, along with inflammation and damage to the liver. Most patients with NASH are not aware that they are suffering from a liver problem. Howe…
- アルコール性肝炎治療の世界市場（～2026年） Alcoholic hepatitis is a kind of liver disease usually affects people who are used to be heavy drinkers. It can cause short and long-term liver damage. Liver is a major organ of body functions to remove poisons such as alcohol from blood. It’s damaged by long time heavy drinking of alcohol. Usually …
- アルコールティーの世界市場（～2026年） Today’s millennials are consuming tea as on-the-go beverages. According to World Tea News, in a forecast by Packaged Facts, the foodservice tea market will likely have an edge in future growth momentum as sales are expected to increase through 2018 and beyond further driving the sales of alcoholic t…
- アルコール飲料用包装の世界市場（～2026年） Alcoholic beverage packaging provides packaging for beverages that contain alcohol. Packaging containers are used for the storage of alcoholic beverages such as beer, wine, vodka, whiskey, rum, and champagne. The European region Alcoholic Beverage Packaging market is projected to grow at the highest…